Sitemap
Pages
- Blog
- Book Event
- Contact
- Corporate
- Home
- Media
- News & Events
- OptiBiotix Brochures
- Over The Counter Podcast: Prescription Slimming Drugs And Their OTC Alternatives
- Policies
- Products
- Publications
- Science & Technology
- Sitemap
- SlimBiome Brochures
- Store
- Technology
Posts by category
- Category: Blogs
- Injectable weight loss drugs: Are they the holy grail?
- The triple threat: Probiotics and their evolution in heart, cognitive and gut health
- Conscious eating and its impact on lowering blood pressure
- Celebrate good gut and microbiome health on World Microbiome Day
- Weighing up injectable drugs: Is it the best ‘shot’ for weight loss?
- Get the balance right and prevent overindulgence this Holiday Season!
- How science-backed innovations can support cardiovascular health this World Heart Day
- How LeanBiome® helps sports enthusiasts to refuel, recover and stay lean
- Tackling the ‘silent killer’ on World Hypertension Day
- OptiBiotix backs WHO ‘Our Planet, Our Health’ campaign
- Trusting the gut – how can consumers improve their gut microbiome balance?
- How do microbes in the gut affect human behaviour?
- Reducing bad cholesterol with LPLDL
- How SlimBiome helps consumers beat the January blues
- Weight loss trends driving market evolution through 2022
- Managing cholesterol over 40 with CholBiome®
- Supporting partners at key events through 2021
- Joining forces to stop the rise of cholesterol
- How ProBiotix Health is helping the hearts of the nation with LPLDL®
- SlimBiome® – your weight management solution through Autumn & Winter
- How mental health can be influenced by the gut microbiome
- Make the most of summer with a healthy gut
- Making the complex simple with LPLDL®, the probiotic for heart health
- Can ice cream be good for the gut?
- The Importance of Sustainability on World Microbiome Day 2021
- Exploring the connection between the gut microbiome and brain
- Why is hypertension a rising concern?
- OptiBiotix is supporting World Health Day 2021 to build a fairer, healthier world
- What’s good for the gut this National Nutrition Month?
- Willpower versus Science: How consumers can manage weight effectively
- What is the human microbiome and why are we so fascinated with it?
- Top Heart Health & Wellness Trends for 2021
- Protecting healthy cholesterol levels this Christmas
- The future of supplements and on-the-go health
- Back to Basics with the OptiBiotix Guide to Prebiotics
- Why LPLDL® is the perfect choice for your health food supplement range this National Cholesterol Month
- Understanding Hypertension During National Know Your Numbers! Week
- Top Five Summer Health & Wellness Tips for Businesses
- Celebrating World Microbiome Day: Why diversity leads to great gut health
- Top Three Tips: How to manage your weight in the ‘new normal’
- Remembering World Health Day: How to stay healthy in today’s climate
- Gut Health: Three ways consumers can make healthier decisions and stick to them
- How to identify the signs of poor gut health
- The ultimate guide to probiotics
- OptiBiotix CEO: Why wait for Diet Pills when the Future is Here Now?
- Are our gut microbes the key to health and happiness?
- The Blurring Lines of Pharma & Nutrition
- What is the difference between pre and pro-biotics?
- Microbiome, Probiotics and Heart Health
- OptiBiotix makes the sugar tax taste sweeter
- New Year, new you: harnessing the microbiome for stress-free living
- Introducing the microbiome: The next frontier in human health
- Category: Commercial Media
- Groundbreaking LPLDL® cholesterol study nominated for NutraIngredients award
- Latest LPLDL® human intervention study from ProBiotix Health highlights ‘promising findings’ on cholesterol reduction
- OptiBiotix targets sports nutrition market with launch of LeanBiome™
- OptiBiotix signs exclusive sales and distribution agreement with leading Saudi pharma chain, Nahdi Medical Co
- British Retail Consortium Accreditation backs OptiBiotix health and wellness solutions
- OptiBiotix launches subsidiary company in India
- SlimBiome® from OptiBiotix achieves Health Canada approval
- SlimBiome® from OptiBiotix takes Weight Maintenance top spot in Nutrition Industry Executive 2021 Awards
- OptiBiotix targets healthy snacking market with launch of high fibre fruit gummies featuring WellBiome®
- ProBiotix Health CholBiome®X3 shortlisted for second consecutive year in NutraIngredients Asia 2021 Awards
- ProBiotix enters exclusive South Korean distribution deal for CholBiome®
- OptiBiotix shortlisted in prestigious FDF Awards
- OptiBiotix Health launches new and improved CholBiome®X3 dosage form
- Probiotix Health Expands In North America With Genuine Health Partnership
- OptiBiotix Announces OptiBiome® To Launch In Australia & New Zealand Under Optislim™ Brand
- OptiBiotix launches new OptiBiome® website for Colombia, Guatemala and Dominican Republic in collaboration with CTC Group
- ProBiotix Health launches Blood Pressure reducing supplement CholBiome®BP
- OptiBiotix launches SlimBiome® Indonesian Website with CTC Group
- Optibiotix Announces Extension Of Commercial Terms For Wellbiome® & Cholbiome® With Global Partners
- Probiotix Health CholBiome® X3 shortlisted in prestigious NutraIngredients Asia Awards 2020
- OptiBiotix Launches WellBiome®: A Revolutionary Ingredient To Support Digestive, Cardiovascular & Metabolic Health
- OptiBiotix adds GoFigure flapjack flavour in celebration of World Microbiome Day
- OptiBiotix launches SlimBiome® Australia Website with Maxum Foods
- OptiBiotix adds new GoFigure porridge to its consumer weight management range
- OptiBiotix launches SnackSmart High Fibre Gummies incorporating SlimBiome® weight management ingredient
- OptiBiotix announces new deal with French manufacturer Laboratoire PYC to create meal replacement shake range with SlimBiome® technology
- OptiBiotix partners with Fipros A/S for European supply of SlimBiome® weight management ingredient
- OptiBiotix announces global deal with Australia’s OptiPharm for distribution of OptiBiome® weight management technology in over 20 new countries
- ProBiotix Health CholBiome®X3 shortlisted in the Nutraingredients Awards 2020
- OptiBiotix extends East European sales of GoFigure® with distribution partner Extensor
- OptiBiotix announces Italian market first with pioneering supplement for cholesterol health
- Mikkel Hvid-Hansen appointed European Sales Director of ProBiotix Health
- New agreement sees terms and territories extended for SlimBiome®, SlimBiome® Medical and GoFigure® distribution
- SlimBiome Medical achieves significant quality and safety certification
- CholBiome®x3 to bring non-pharmaceutical cholesterol management to the Philippines
- New GoFigure Website Launches in Poland
- LPLDL® achieves GRAS status
- LPLDL® successfully completes pharma level GMP validation
- GoFigure® scoops top consumer award
- OptiBiotix online store celebrates successful first year
- OptiBiotix drives growth of SlimBiome® technology with new distribution deal
- OptiBiotix® increases retail presence of CholBiome® in Bulgarian market
- OptiBiotix SlimBiome® Medical shortlisted for top industry award
- OptiBiotix brings SlimBiome® technology to growing North American weight management market
- OptiBiotix GoFigure® Muesli Pots passes first judging stage for prestigious award
- Award-winning GoFigure® products to be made available in Poland
- Student scoops National Young Scientist prize based on OptiBiotix products
- New LPLDL® Application In Development Following License Agreement
- OptiBiotix to Launch SlimBiome® Medical at Vitafoods 2019
- OptiBiotix Brings Weight Management Solution SlimBiome® Medical to UK Market
- OptiBiotix CholBiome®X3 Shortlisted for Industry Award
- OptiBiotix studies reveal promising link between gut microbiome and good health
- IPA appointment sees OptiBiotix pioneer a probiotic future
- OptiBiotix appoints nutritional specialist to lead prebiotic and SweetBiotix®
- OptiBiotix signs agreement to distribute LPLDL® across Japan
- OptiBiotix partners with Biolat to distribute LPLDL® across Europe
- Next generation microbiome weight management product reduces hunger and food cravings leading to weight loss
- OptiBiotix sweet fibres show mircrobiome modulating effect and the potential for human health benefits
- OptiBiotix Expands Distribution Infrastructure Taking CholBiome® Global
- OptiBiotix Launches SlimBiome® Medical in Time for Festive Season
- OptiBiotix Extends CholBiome® Cholesterol Management Range
- OptiBiotix Continues to Drive Growth of SlimBiome® with Latest Distribution Deals
- OptiBiotix Blossoming in Growing Global Probiotic Market
- OptiBiotix’s LPLDL® Shortlisted for Industry Award
- Seed Health – In Collaboration with OptiBiotix – Name 2018 CPG Editor’s Choice Award Finalist
- OptiBiotix to Serve U.S Market with Innovative LPLDL® Product Offer
- OptiBiotix continues LPLDL® growth with latest CholBiome® distribution deal
- OptiBiotix launches CHOLBIOME® cholesterol management range
- OptiBiotix launches online store
- OptiBiotix appoints Dr Sofia Kolyda as new Director of Research and Development
- SkinBioTherapeutics receives provisional ethics approval for human study
- OptiBiotix enters into partnership agreement with Morley Foods
- OptiBiotix expands USA presence with seed health product launch
- GoFigure® meal replacement shakes are proud to be backed by OptiBiotix science
- SlimBiome wins ‘Weight Management Ingredient of the Year’ at NutraIngredients Awards
- OptiBiotix wins prestigious Nutraingredients award
- OptiBiotix signs agreement with Akums at Vitafoods 2018
- OptiBiotix extends SlimBiome® commercial reach with Cambridge Commodities agreement
- OptiBiotix double finalist success in Nutraingredients awards
- Category: Events
- LPLDL study presentation recognised at Probiota 2020
- Dr Sofia Kolida to present at Probiota 2020
- SlimBiome® to showcase at SupplySide West
- OptiBiotix showcasing SlimBiome® and SweetBiotix® at international conference
- OPTIBIOTIX EXHIBITS WITH NUTRILINEA AT VITAFOODS 2019
- OptiBiotix To Demonstrate Microbiome Expertise At Probiota 2019
- OptiBiotix to Exhibit Revolutionary CholBiome® Range at Food Matters Live 2018
- OptiBiotix Founder to Speak at Food Matters Live London 2018
- OptiBiotix to Showcase Next-Generation Microbiome Solutions at SupplySide® West
- OptiBiotix to showcase SlimBiome at IFT 18
- OptiBiotix to present IPGOS study results at IPC 2018
- OptiBiotix to present at microbiome invest congress 2018
- OptiBiotix to present LPLDL® study results at Probiota Americas
- OptiBiotix to showcase pioneering health products at Vitafoods Europe
- OptiBiotix to showcase SlimBiome® applications at 2018 Natural products Expo West Engredea Show
- Category: Investor Media
- Paul Cannings appointed Head of Operations & Quality at OptiBiotix
- OptiBiotix leads sector with surging half year interim sales figures
- OptiBiotix Health announces René Kamminga as CEO of its subsidiary OptiBiotix Ltd
- OptiBiotix Health Plc Announces New Non-Executive Director
- Optibiotix Health Plc Announces New Company Director
- Probiotix Health Announces Further Product Commercialisation Progress
- ProBiotix Health Announces Major APAC Distribution Deal with Actial Farmaceutica for CholBiome®
- Optibiotix announces major uk distribution deal with Cambridge Commodities Ltd
- OptiBiotix announces three major deals with partners in US and Asia
- OptiBiotix partners with Prosperous Pharma to bring SlimBiome® Medical to the Middle East
- OptiBiotix launches contemporary new SlimBiome® website to support customers in the Philippines
- ProBiotix Health partners with Velinoff Pharma to bring CholBiome® and CholBiome® X3 to Bulgarian market
- ProBiotix Health extends agreement with Sacco S.r.l. for the manufacturing and supply of its patented probiotic strain LPLDL until 2023
- A Thriving Partnership: OptiBiotix meets with Maxum Foods in Australia to continue SlimBiome® success
- OptiBiotix partners with Select Ingredient to bring its patented probiotic strain LPLDL to the US and Canadian markets
- OptiBiotix announces partnership with Granja Pocha to develop dairy product range containing LPLDL in Uruguay, South America
- OptiBiotix launches SlimBiome® to North American market in partnership with Agropur Inc.
- Duo of new SlimBiome® products to launch in India
- OptiBiotix announces trio of new commercial agreements
- OptiBiotix prepares for CholBiomeX3 launch with Akums Pharmaceuticals
- Optibiotix launches ProBiotix Health as a separate company, which could lead to an IPO
- OptiBiotix launches new subsidiary: ProBiotix Health Ltd.
- U.S pharma deal signals major breakthrough for OptiBiotix probiotics range
- OptiBiotix enters agreement with Fine Foods Pharmaceuticals
- Category: News
- ProBiotix Health highlights LPLDL® and new products to support cardiometabolic health at SupplySide West
- OptiBiotix to launch its finished product WellBiome® for the US market at SupplySide West
- ProBiotix Health expands heart health range with CholBiome®VH
- Consumers hungry for weight loss and an industry craving for innovation – what next for the injectable revolution?
- ProBiotix Health launches new dual-action cholesterol reducing bi-layer tablet CholBiome®CH at Vitafoods Europe
- OptiBiotix to launch new WellBiome® solution for wellbeing and healthy ageing consumer market at Vitafoods Europe 2023
- OptiBiotix launches GoFigure® in Saudi Arabia to help combat ‘alarming’ obesity rates in population
- OptiBiotix to showcase its progressive microbiome research at Probiota 2023
- OptiBiotix: Scientific community must double-down on efforts to reduce cardiovascular risk following presentation at US Global Engage Conference
- OptiBiotix to launch WellBiome® reformulation at SupplySide West 2022
- OptiBiotix launches highly effective low dose prebiotic to stimulate targeted gut microbial growth
- OptiBiotix launches GoFigure® weight management range in India with Apollo Hospitals
- OptiBiotix to exhibit award-winning microbiome modulation solutions at IFT Chicago
- OptiBiotix builds on its leading microbiome presence after floating ProBiotix Health subsidiary on AQSE Growth Market
- LPLDL® from ProBiotix Health showcases statistically significant reductions in multiple coronary heart disease biomarkers in hypercholesterolemic adults
- OptiBiotix jointly funds new research project to understand how its microbiome modulation technologies could improve sleep, stress & anxiety
- New research indicates microbiome-modulator SlimBiome® may help to reduce weight, BMI and body fat
- New study reveals SlimBiome® benefits in managing obesity related health outcomes
- OptiBiotix Health Plc. Covid 19 (‘Corona Virus’) Statement
- New OptiBiotix Health LPLDL® formulation demonstrates blood pressure reduction in new human study
- OptiBiotix receives CE mark approval for SlimBiome® weight management product
- Scientific success leads to strong portfolio of commercial deals for UK-based microbiome company, OptiBiotix Health
- Study shows novel probiotic reduces cholesterol more effectively than plant sterols/stanols
- OptiBiotix Health launches new website
- OptiBiotix strengthens patent protection around low-calorie sweeteners
- Weight management technology to reduce weight gain risk of high-sugar cereal products
- Promising results from study show that zero-calorie prebiotic sweeteners could replace sugar in food and drink products
- Category: Scientific Media
- Category: Uncategorized
- Category: Partner Q&A